Low Dose Tamoxifen for Mammographic Density Reduction
NCT03346200
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1440
Enrollment
OTHER
Sponsor class
Conditions
Risk Reduction
Mammographic Density Reduction
Interventions
DRUG:
Tamoxifen Oral Tablet
DRUG:
Placebo Oral Tablet
Sponsor
Per Hall